AVR logo

Anteris Technologies Global CHIA:AVR Stock Report

Last Price

AU$9.61

Market Cap

AU$346.5m

7D

4.5%

1Y

-41.4%

Updated

19 Jan, 2025

Data

Company Financials +

Anteris Technologies Global Corp.

CHIA:AVR Stock Report

Market Cap: AU$346.5m

AVR Stock Overview

A structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. More details

AVR fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Revenue is forecast to grow 70.6% per year

Analysts in good agreement that stock price will rise by 222.4%

Risk Analysis

Shareholders have been substantially diluted in the past year

Currently unprofitable and not forecast to become profitable over the next 3 years

Does not have meaningful revenue ($3M)


My Notes

Capture your thoughts, links and company narrative

Anteris Technologies Global Corp. Competitors

EBR Systems

ASX:EBR

AU$548.4m

Cyclopharm

ASX:CYC

AU$238.9m

Respiri

ASX:RSH

AU$101.4m

Optiscan Imaging

ASX:OIL

AU$142.0m

Price History & Performance

Summary of share price highs, lows and changes for Anteris Technologies Global
Historical stock prices
Current Share PriceAU$9.61
52 Week HighAU$23.60
52 Week LowAU$7.71
Beta0.76
1 Month Change7.49%
3 Month Change-17.93%
1 Year Change-41.37%
3 Year Change-42.68%
5 Year Change-16.43%
Change since IPO-86.88%

Recent News & Updates

Recent updates

Shareholder Returns

AVRAU Medical EquipmentAU Market
7D4.5%1.3%0.1%
1Y-41.4%6.3%9.8%

Return vs Industry: AVR underperformed the Australian Medical Equipment industry which returned 6.3% over the past year.

Return vs Market: AVR underperformed the Australian Market which returned 9.8% over the past year.

Price Volatility

Is AVR's price volatile compared to industry and market?
AVR volatility
AVR Average Weekly Movement11.6%
Medical Equipment Industry Average Movement10.0%
Market Average Movement7.9%
10% most volatile stocks in AU Market16.6%
10% least volatile stocks in AU Market2.9%

Stable Share Price: AVR has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: AVR's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999138Wayne Patersonanteristech.com

Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta.

Anteris Technologies Global Corp. Fundamentals Summary

How do Anteris Technologies Global's earnings and revenue compare to its market cap?
AVR fundamental statistics
Market capAU$346.46m
Earnings (TTM)-AU$115.82m
Revenue (TTM)AU$4.56m

75.9x

P/S Ratio

-3.0x

P/E Ratio

Is AVR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AVR income statement (TTM)
RevenueUS$2.83m
Cost of RevenueUS$833.67k
Gross ProfitUS$1.99m
Other ExpensesUS$73.76m
Earnings-US$71.77m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-2.00
Gross Margin70.51%
Net Profit Margin-2,538.93%
Debt/Equity Ratio37.7%

How did AVR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/19 11:08
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Anteris Technologies Global Corp. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matt MiksicBarclays
Ross OsbornCantor Fitzgerald & Co.
Andrew ScottCGS International